Impact Biomedical Inc. Insider Trading

IBO

Last 12 months

Insiders sold 58K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Jason Grady sold 33K on Mar 23, 17% of their stake, outside a plan. The last open-market buy by an executive or director was in Dec 2024.

Net open-market

−58K

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Dec 2024

Dec 5, 2024

Get an email when IBO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 22 – 24	Dss, Inc. Large holder	SoldNo plan 3 parts	906	$7.04 average	1K	0.2%	Form 4
Mar 25 – 27	Todd D Macko Chief Financial Officer	SoldNo plan 2 parts	45,000	$0.56 average	25K	22%	Form 4
Mar 23	Jason Grady Director	SoldNo plan	50,000	$0.65	33K	17%	Form 4
May 22, 2025 – May 27, 2025	Dss, Inc. Large holder	SoldNo plan 2 parts	161,000	$0.55 average	88K	23%	Form 4
May 22, 2025 – May 27, 2025	Dss, Inc. Large holder	SoldNo plan 2 parts	161,000	$0.55 average	88K	100%	Form 4
Apr 4, 2025	Dss, Inc. Large holder	SoldNo plan	890,800	$0.95	846K	40%	Form 4
Apr 2, 2025 – Apr 4, 2025	Alset Inc. Large holder	SoldNo plan 7 parts	1,689,693	$0.66 average	$1.12M	100%	Form 4
Apr 3, 2025	Heng Fai Ambrose Chan Director	SoldNo plan	351,555	$0.50	176K	100%	Form 4
Mar 31, 2025 – Apr 1, 2025	Alset International Ltd Large holder	SoldNo plan 4 parts	2,526,918	$1.15 average	$2.91M	77%	Form 4
Mar 21, 2025 – Mar 27, 2025	Dss, Inc. Large holder	SoldNo plan 6 parts	605,620	$3.22 average	$1.95M	21%	Form 4
Dec 2, 2024 – Mar 20, 2025	Dss, Inc. Large holder	SoldNo plan 2 parts	53,300	$4.68 average	249K	3.1%	Form 4
Mar 20, 2025	Dss, Inc. Large holder	Bought	200	$1.55	$310	<0.1%	Form 4
Dec 5, 2024	Frank D Heuszel Chief Executive Officer	Bought	500	$2.26	1K	0.5%	Form 4
Nov 27, 2024	Frank D Heuszel Chief Executive Officer	Bought	500	$2.61	1K	0.5%	Form 4
Nov 26, 2024	Frank D Heuszel Chief Executive Officer	Bought 2 parts	1,050	$2.61 average	3K	1.1%	Form 4
Nov 12, 2024 – Nov 18, 2024	Dss, Inc. Large holder	SoldNo plan 3 parts	5,700	$2.99 average	17K	0.3%	Form 4

Sep 22 – 24No plan
Dss, Inc.
Large holder · sold 906 at avg $7.04
1K
0.2% of stake
Mar 25 – 27No plan
Todd D Macko
Chief Financial Officer · sold 45,000 at avg $0.56
25K
22% of stake
Mar 23No plan
Jason Grady
Director · sold 50,000 at $0.65
33K
17% of stake
May 22, 2025 – May 27, 2025No plan
Dss, Inc.
Large holder · sold 161,000 at avg $0.55
88K
23% of stake
May 22, 2025 – May 27, 2025No plan
Dss, Inc.
Large holder · sold 161,000 at avg $0.55
88K
100% of stake
Apr 4, 2025No plan
Dss, Inc.
Large holder · sold 890,800 at $0.95
846K
40% of stake
Apr 2, 2025 – Apr 4, 2025No plan
Alset Inc.
Large holder · sold 1,689,693 at avg $0.66
$1.12M
100% of stake
Apr 3, 2025No plan
Heng Fai Ambrose Chan
Director · sold 351,555 at $0.50
176K
100% of stake
Mar 31, 2025 – Apr 1, 2025No plan
Alset International Ltd
Large holder · sold 2,526,918 at avg $1.15
$2.91M
77% of stake
Mar 21, 2025 – Mar 27, 2025No plan
Dss, Inc.
Large holder · sold 605,620 at avg $3.22
$1.95M
21% of stake
Dec 2, 2024 – Mar 20, 2025No plan
Dss, Inc.
Large holder · sold 53,300 at avg $4.68
249K
3.1% of stake
Mar 20, 2025
Dss, Inc.
Large holder · bought 200 at $1.55
$310
<0.1% of stake
Dec 5, 2024
Frank D Heuszel
Chief Executive Officer · bought 500 at $2.26
1K
0.5% of stake
Nov 27, 2024
Frank D Heuszel
Chief Executive Officer · bought 500 at $2.61
1K
0.5% of stake
Nov 26, 2024
Frank D Heuszel
Chief Executive Officer · bought 1,050 at avg $2.61
3K
1.1% of stake
Nov 12, 2024 – Nov 18, 2024No plan
Dss, Inc.
Large holder · sold 5,700 at avg $2.99
17K
0.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IBO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with IBO

CompareIntrinsic value

LYELLyell Immunopharma, Inc.

$15.43+43.27%10

GRDXGridAI Technologies Corp.

$5.43+12.42%0

NTHINeonC Technologies Holdings

$3.17+3.26%10

BDPTBioadaptives Inc.

$0.00-5.88%25

ALTAltimmune, Inc.

$2.12+3.92%10

JUNSJupiter Neurosciences Inc.

$2.46+1.23%10

SKVISkinvisible Inc.

$0.16+0.00%0

ADTXAditxt Inc.

$0.00+33.33%20

Spot a number that looks wrong? Check it in IBO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IBO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.